Tags

Type your tag names separated by a space and hit enter

Psoriasis in France and associated risk factors: results of a case-control study based on a large community survey.
Dermatology 2009; 218(2):103-9D

Abstract

BACKGROUND

Risk factors for psoriasis have been identified.

OBJECTIVE

To precisely define these associated factors.

METHODS

A survey was conducted using a questionnaire on a representative sample of the French population. A case-control study was conducted. Cases were persons who declared having had psoriasis during the previous 12 months. For each case, 3 matched controls were selected. Cases and controls were compared using univariate and multivariate analyses.

RESULTS

The questionnaire was filled out and returned by 6,887 (68.9%) of 10,000 subjects aged 15 years and over; 356 cases were identified. In multivariate analysis, a higher body mass index, current and former smoking habits and beta-blocker intake were independently associated with a higher risk of psoriasis; intake of statins was associated with a decreased risk (p < 0.05).

CONCLUSIONS

We confirmed the association of overweight, smoking habits and beta-blocker intake with psoriasis and reported a decreased risk associated with statin intake.

Authors+Show Affiliations

Department of Dermatology, Albert Chenevier-Henri Mondor, Faculty of Medicine, Paris 12 University, Créteil, France. pierre.wolkenstein@hmn.aphp.frNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

19060463

Citation

Wolkenstein, P, et al. "Psoriasis in France and Associated Risk Factors: Results of a Case-control Study Based On a Large Community Survey." Dermatology (Basel, Switzerland), vol. 218, no. 2, 2009, pp. 103-9.
Wolkenstein P, Revuz J, Roujeau JC, et al. Psoriasis in France and associated risk factors: results of a case-control study based on a large community survey. Dermatology (Basel). 2009;218(2):103-9.
Wolkenstein, P., Revuz, J., Roujeau, J. C., Bonnelye, G., Grob, J. J., & Bastuji-Garin, S. (2009). Psoriasis in France and associated risk factors: results of a case-control study based on a large community survey. Dermatology (Basel, Switzerland), 218(2), pp. 103-9. doi:10.1159/000182258.
Wolkenstein P, et al. Psoriasis in France and Associated Risk Factors: Results of a Case-control Study Based On a Large Community Survey. Dermatology (Basel). 2009;218(2):103-9. PubMed PMID: 19060463.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Psoriasis in France and associated risk factors: results of a case-control study based on a large community survey. AU - Wolkenstein,P, AU - Revuz,J, AU - Roujeau,J C, AU - Bonnelye,G, AU - Grob,J J, AU - Bastuji-Garin,S, AU - ,, Y1 - 2008/12/06/ PY - 2008/07/21/received PY - 2008/09/18/accepted PY - 2008/12/9/pubmed PY - 2009/6/16/medline PY - 2008/12/9/entrez SP - 103 EP - 9 JF - Dermatology (Basel, Switzerland) JO - Dermatology (Basel) VL - 218 IS - 2 N2 - BACKGROUND: Risk factors for psoriasis have been identified. OBJECTIVE: To precisely define these associated factors. METHODS: A survey was conducted using a questionnaire on a representative sample of the French population. A case-control study was conducted. Cases were persons who declared having had psoriasis during the previous 12 months. For each case, 3 matched controls were selected. Cases and controls were compared using univariate and multivariate analyses. RESULTS: The questionnaire was filled out and returned by 6,887 (68.9%) of 10,000 subjects aged 15 years and over; 356 cases were identified. In multivariate analysis, a higher body mass index, current and former smoking habits and beta-blocker intake were independently associated with a higher risk of psoriasis; intake of statins was associated with a decreased risk (p < 0.05). CONCLUSIONS: We confirmed the association of overweight, smoking habits and beta-blocker intake with psoriasis and reported a decreased risk associated with statin intake. SN - 1421-9832 UR - https://www.unboundmedicine.com/medline/citation/19060463/Psoriasis_in_France_and_associated_risk_factors:_results_of_a_case_control_study_based_on_a_large_community_survey_ L2 - https://www.karger.com?DOI=10.1159/000182258 DB - PRIME DP - Unbound Medicine ER -